Organizer
Wiley
Wiley
For over 200 years we have been helping people and organizations develop the skills and knowledge they need to succeed. We develop digital education, learning, assessment, and certification solutions to help universities, businesses, and individuals move between education and employment and achieve their ambitions.
Tags
LC/MS
LC/MS/MS
LC/TOF
LC/HRMS
LinkedIn Logo

Improving NPS forensic testing with metabolite profiling

RECORD | Already taken place We, 29.11.2023
In this webinar, we will illustrate how to achieve metabolite profiling across various NPS classes using a combined in vitro and in vivo workflow.
Go to the webinar
SCIEX: Improving NPS forensic testing with metabolite profiling
SCIEX: Improving NPS forensic testing with metabolite profiling

The emergence of novel psychoactive substances (NPS) in the recreational drug market poses a growing challenge for the forensic and medical communities worldwide. These synthetic drugs, which are continually evolving in nature and properties, have emerged as potent alternatives to controlled opioids. Often used as adulterants or cutting agents for commonly abused drugs, they raise serious safety concerns for both public health and law enforcement officials. Initial identification of these emerging drugs can be challenging for forensic toxicology laboratories due to the lack of information about their molecular structure and metabolomic pathway. In this context, the use of accurate mass screening workflows with data-independent acquisition (DIA) methods has proven to be a comprehensive tool for the characterization of NPS metabolism.

In this webinar, we will illustrate how to achieve metabolite profiling across various NPS classes using a combined in vitro and in vivo workflow. We will demonstrate how metabolites generated using human liver microsomes can be analyzed via liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) to generate in vitro metabolic profiles of various NPS. In this workflow, the characterized metabolites are verified in vivo by analyzing various authentic human biological samples collected after analytically confirmed cases of ingestion and/or overdose.

This novel approach enables the characterization and identification of several phase-I and glucuronide-phase-II NPS metabolites, providing a comprehensive overview of the metabolic profiles of emerging NPS. The resulting insights offer valuable evidence to inform future toxicology analysis and forensic interpretation of cases involving drug use.

Presenter: Marta Massano (PhD student in Sustainable Development and Cooperation (SUSTNET), University of Turin)

Presenter: Alex Krotulski (Associate Director at CFSRE, Program Manager for NPS Discovery, The Center for Forensic Science Research and Education (CFSRE))

Wiley
LinkedIn Logo
 

Related content

Two-Step Matrix Deposition for Improved MS Imaging Resolution

Posters
| 2026 | Shimadzu (ASMS)
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, MALDI, MS Imaging
Manufacturer
Shimadzu
Industries
Pharma & Biopharma

Smart Monitoring & Optimization Solutions for SMB Processes: In-Line and Off-Line Tools for SMB Systems

Technical notes
| 2026 | KNAUER
Instrumentation
HPLC
Manufacturer
KNAUER
Industries
Pharma & Biopharma

Xevo MRT P10 Mass Spectrometer

Brochures and specifications
| 2026 | Waters
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Metabolomics, Proteomics , Lipidomics

Large-Volume Dilute-and-Shoot Analysis of PFAS in Drinking Water Using the Altura PFAS Column

Applications
| 2026 | Agilent Technologies
Instrumentation
Consumables, LC columns, LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Agilent Technologies
Industries
Environmental

Hey, ho, oliGO – Comparison of ion-pairing systems for oligonucleotide analysis with HPLC-UV

Applications
| 2026 | KNAUER
Instrumentation
Consumables, LC columns, HPLC
Manufacturer
KNAUER
Industries
Pharma & Biopharma
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike